# AZD8529 Single Ascending Dose Study

> **NCT00755378** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 58 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD8529
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00755378
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** —
- **Final completion:** 2009-03
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2009-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755378, "AZD8529 Single Ascending Dose Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00755378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*